Sex-related differences in genetically determined Alzheimer’s disease
Authors:
Open Access
- 4 March 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 17, 1522434
Abstract
We reviewed the literature on sex differences in genetically determined Alzheimer’s disease (AD), focusing on autosomal dominant AD (ADAD), Down syndrome-associated AD (DSAD), and APOE4 homozygosity, particularly regarding disease penetrance, symptom onset and clinical progression, and trajectories for markers of amyloidosis (A), tau pathology (T) and neurodegeneration (N). Data suggests that sex differences in disease penetrance, symptom onset, and AT(N) biomarker trajectories are typically subtle for genetically determined AD populations. Noteworthy exceptions, such as increased neurodegeneration in later stages of the disease in females while similar cognitive outcomes, suggest a potential differential cognitive reserve that warrants further investigation. Additionally, the interaction between APOE genotype and sex reveals complex and multifaceted effects in DSAD, with potential implications for ADAD that remain underexplored. The smaller sex differences observed compared to sporadic AD offer insights into the different underlying disease mechanisms in genetically determined AD populations. Future research should prioritize sex-specific investigations in genetically determined AD, focusing on refining methodologies. This includes prioritizing longitudinal designs, adjustment for key confounders, and adherence to sex-specific guidelines.Keywords
Funding Information
- National Institutes of Health
- Generalitat de Catalunya
- Fundación Tatiana Pérez de Guzmán el Bueno
This publication has 97 references indexed in Scilit:
- Association of Alzheimer Disease With Life Expectancy in People With Down SyndromeJAMA Network Open, 2022
- Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian CohortJAMA Network Open, 2021
- Evaluation of Selective Survival and Sex/Gender Differences in Dementia Incidence Using a Simulation ModelJAMA Network Open, 2021
- Epidemiology of Dementia and Alzheimer Disease in Individuals With Down SyndromeJAMA Neurology, 2020
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in NeurologyJAMA Neurology, 2019
- Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older AdultsJAMA Neurology, 2019
- Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer DiseaseJAMA Neurology, 2016
- Prevalence of Cerebral Amyloid Pathology in Persons Without DementiaJAMA, 2015
- The APOE-∊4 Allele and the Risk of Alzheimer Disease Among African Americans, Whites, and HispanicsJAMA, 1998
- Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer DiseaseJAMA, 1997